Revance Therapeutics, Inc Overview
Company Headquarters: California, US
Founded: 1999
Workforce: ~150+
Company Working:
Revance Therapeutics, Inc.is a global healthcare company engaged in the development, manufacture, distribution of botulinum, and other aesthetics & skincare products. The company is a market leader in developing neuromodulators for the treatment of aesthetic and therapeutic conditions. Revance has a strong R&D department, which is providing innovative products. It is pursuing product approval for its blockbuster innovation DaxibotulinumtoxinA for Injection (DAXI) for treatment of crow’s feet, cervical dystonia, adult upper limb spasticity and plantar fasciitis. The company is anticipated to capture significant market share in the therapeutic segment in the botulinum toxin market owing to the strong pipeline.
Strategy
Revance Therapeutics, Inc. is investing a huge amount into conducting clinical trials and developing neuromodulator products for aesthetics and therapeutic purpose. The company aims to become a global leader in the aesthetics and skincare market, and it has been developing the botulinum toxin injectables with the unique dosage form. Additionally, it is focusing on strategic partnerships and collaborations with local players to expand its geographical presence.
